Radiation therapy effectively treats orbital lymphomas with few adverse effects, but treatment with monoclonal antibodies (eg, rituximab) against a surface receptor (eg, CD20) on the lymphocyte is also effective and should be considered in addition to or instead of radiation therapy, particularly if lymphoma is systemic.